Lingyan Cui

State Key Laboratory Of Vaccines For Infectious Diseases
Xiamen, 361102, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Combination mRNA Vaccine Adjuvanted with CpG Oligodeoxynucleotides Enhances Protection against Respiratory Virus Infection.

Combination mRNA Vaccine Adjuvanted with CpG Oligodeoxynucleotides Enhances Protection against Respiratory Virus Infection.

Journal: ACS nano
Published: March 30, 2026

A modular nanoparticle display strategy for varicella-zoster virus gE based on a licensed protein scaffold.

A modular nanoparticle display strategy for varicella-zoster virus gE based on a licensed protein scaffold.

Journal: PLoS pathogens
Published: October 30, 2025

Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infections.

Nanobody-based combination vaccine using licensed protein nanoparticles protects animals against respiratory and viral infections.

Journal: Nature biomedical engineering
Published: May 02, 2025

Research Progress on Varicella-Zoster Virus Vaccines.

Research Progress on Varicella-Zoster Virus Vaccines.

Journal: Vaccines
Published: April 30, 2025

Immunogenicity and cellular response of a herpes zoster virus gEgI fusion protein adjuvanted with CpG-emulsion in mice.

Immunogenicity and cellular response of a herpes zoster virus gEgI fusion protein adjuvanted with CpG-emulsion in mice.

Journal: Journal of nanobiotechnology
Published: December 24, 2024

Glycoprotein E-Displaying Nanoparticles Induce Robust Neutralizing Antibodies and T-Cell Response against Varicella Zoster Virus.

Glycoprotein E-Displaying Nanoparticles Induce Robust Neutralizing Antibodies and T-Cell Response against Varicella Zoster Virus.

Journal: International journal of molecular sciences
Published: July 30, 2024

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants.

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants.

Journal: Viruses
Published: April 08, 2024

A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates.

A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates.

Journal: iScience
Published: December 05, 2023

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD.

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD.

Journal: Protein & cell
Published: February 14, 2023

Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice.

Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice.

Journal: Viruses
Published: August 04, 2022

Genetic engineering of baculovirus-insect cell system to improve protein production.

Genetic engineering of baculovirus-insect cell system to improve protein production.

Journal: Frontiers in bioengineering and biotechnology
Published: July 15, 2022

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses.

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses.

Journal: Nature communications
Published: March 22, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026